{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:12:55Z","timestamp":1761765175444},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T00:00:00Z","timestamp":1246492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s11255-009-9600-7","type":"journal-article","created":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T03:44:11Z","timestamp":1246419851000},"page":"383-391","source":"Crossref","is-referenced-by-count":17,"title":["Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery"],"prefix":"10.1007","volume":"42","author":[{"given":"Michael B.","family":"Chancellor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"9600_CR1","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","volume":"171","author":"CP Smith","year":"2004","unstructured":"Smith CP, Chancellor MB (2004) Emerging role of botulinum toxin in the treatment of voiding dysfunction. J Urol 171:2128\u20132137. doi: 10.1097\/01.ju.0000127725.48479.89","journal-title":"J Urol"},{"key":"9600_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","volume":"13","author":"JO Dolly","year":"2006","unstructured":"Dolly JO, Aoki KR (2006) The structure and mode of action of different botulinum toxins. Eur J Neurol 13:1\u20139. doi: 10.1111\/j.1468-1331.2006.01648.x","journal-title":"Eur J Neurol"},{"key":"9600_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","volume":"5","author":"MB Chancellor","year":"2008","unstructured":"Chancellor MB, Fowler CJ, Apostolidis A, de Groat WC, Smith CP, Somogyi GT, Roger Aoki K (2008) Drug insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 5:319\u2013328","journal-title":"Nat Clin Pract Urol"},{"key":"9600_CR4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","volume":"87","author":"AB Scott","year":"1980","unstructured":"Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044\u20131049","journal-title":"Ophthalmology"},{"key":"9600_CR5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"DD Dykstra","year":"1988","unstructured":"Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139:919\u2013922","journal-title":"J Urol"},{"key":"9600_CR6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692\u2013697. doi: 10.1016\/S0022-5347(05)67283-7","journal-title":"J Urol"},{"key":"9600_CR7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8","volume":"37","author":"R Doggweiler","year":"1998","unstructured":"Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA (1998) Botox induced prostatic involution. Prostate 37:44\u201350. doi: 10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8","journal-title":"Prostate"},{"key":"9600_CR8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0022-5347(05)64261-9","volume":"168","author":"N Yoshimura","year":"2002","unstructured":"Yoshimura N, Chancellor MB (2002) Current and future pharmacological therapy of the overactive bladder. J Urol 168:1897\u20131913. doi: 10.1016\/S0022-5347(05)64261-9","journal-title":"J Urol"},{"key":"9600_CR9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7224\/1537-2073-4.2.70","volume":"4","author":"ML O\u2019Leary","year":"2002","unstructured":"O\u2019Leary ML, Smith CP, Erickson JR, Heyman RA, Chancellor MB (2002) Botulinum toxin urethral sphincter injection to restore bladder emptying in a woman with multiple sclerosis. Int J MS Care 4:70\u201372","journal-title":"Int J MS Care"},{"key":"9600_CR10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","volume":"165","author":"MW Phelan","year":"2001","unstructured":"Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, Yoshimura N, Chancellor MB (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165:1107\u20131110. doi: 10.1016\/S0022-5347(05)66438-5","journal-title":"J Urol"},{"key":"9600_CR11","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","volume":"169","author":"CP Smith","year":"2003","unstructured":"Smith CP, Franks ME, McNeil BK, Chancellor MB (2003) Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 169:1896\u20131900. doi: 10.1097\/01.ju.0000049202.56189.54","journal-title":"J Urol"},{"key":"9600_CR12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0022-5347(05)00318-6","volume":"173","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Huang CC, Kang HY, Chancellor MB (2006) Novel action of botulinum toxin on the somal and epithelial components of prostate gland. J Urol 173:1158\u20131163. doi: 10.1016\/S0022-5347(05)00318-6","journal-title":"J Urol"},{"key":"9600_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-6-12","volume":"6","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Tu CH, Huang CC, Lin HJ, Chiang YC, Yoshimura N, Chancellor MB (2006) Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urol 6:12\u201316. doi: 10.1186\/1471-2490-6-12","journal-title":"BMC Urol"},{"key":"9600_CR14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2007.03.002","volume":"52","author":"AT Lin","year":"2007","unstructured":"Lin AT, Yang AH, Chen KK (2007) Effects of botulinum toxin A on the contractile function of dog prostate. Eur Urol 52:582\u2013589. doi: 10.1016\/j.eururo.2007.03.002","journal-title":"Eur Urol"},{"key":"9600_CR15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.eururo.2006.11.037","volume":"51","author":"YC Chuang","year":"2007","unstructured":"Chuang YC, Yoshimura N, Wu M, Chancellor MB (2007) Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Eur Urol 51:1119\u20131127. doi: 10.1016\/j.eururo.2006.11.037","journal-title":"Eur Urol"},{"key":"9600_CR16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.juro.2006.07.127","volume":"176","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Chancellor MB (2006) The application of botulinum toxin in the prostate. J Urol 176:2375\u20132382. doi: 10.1016\/j.juro.2006.07.127","journal-title":"J Urol"},{"key":"9600_CR17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.urology.2005.04.029","volume":"66","author":"YC Chuang","year":"2005","unstructured":"Chuang YC, Chiang PH, Huang CC, Chancellor MB (2005) Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 66:775\u2013779. doi: 10.1016\/j.urology.2005.04.029","journal-title":"Urology"},{"key":"9600_CR18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1464-410X.2006.06479.x","volume":"98","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Chiang PH, Yoshimura N, Chancellor MB (2006) Sustained beneficial effects of intraprostatic botulinum toxin type A injection on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU Int 98:1033\u20131037. doi: 10.1111\/j.1464-410X.2006.06479.x","journal-title":"BJU Int"},{"key":"9600_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-410X.2006.06184.x","volume":"98","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Giannantoni A, Chancellor MB (2006) The potential and promise of using botulinum toxin in the prostate gland. BJU Int 98:28\u201332. doi: 10.1111\/j.1464-410X.2006.06184.x","journal-title":"BJU Int"},{"key":"9600_CR20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.juro.2007.07.120","volume":"180","author":"YC Chuang","year":"2008","unstructured":"Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB (2008) Intraprostatic botulinum toxin A injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol 180:742\u2013748. doi: 10.1016\/j.juro.2007.07.120","journal-title":"J Urol"},{"key":"9600_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0361-9230(03)00114-X","volume":"61","author":"CP Smith","year":"2003","unstructured":"Smith CP, Boone TB, de Groat WC, Chancellor MB, Somogyi GT (2003) Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions. Brain Res Bull 61:165\u2013169. doi: 10.1016\/S0361-9230(03)00114-X","journal-title":"Brain Res Bull"},{"key":"9600_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ucl.2006.06.010","volume":"33","author":"DK Kim","year":"2006","unstructured":"Kim DK, Thomas CA, Smith C, Chancellor MB (2006) The case for bladder botulinum toxin application. UCNA 33:503\u2013510. doi: 10.1016\/j.ucl.2006.06.010","journal-title":"UCNA"},{"key":"9600_CR23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","volume":"172","author":"YC Chuang","year":"2004","unstructured":"Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB (2004) Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 172:1529\u20131532. doi: 10.1097\/01.ju.0000137844.77524.97","journal-title":"J Urol"},{"key":"9600_CR24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1464-410X.2008.07740.x","volume":"012","author":"CC Chuang","year":"2008","unstructured":"Chuang CC, Kim DK, Chiang PH, Chancellor MB (2008) Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU Int 012:704\u2013706. doi: 10.1111\/j.1464-410X.2008.07740.x","journal-title":"BJU Int"},{"key":"9600_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","volume":"65","author":"CP Smith","year":"2005","unstructured":"Smith CP, Nishiguchi J, O\u2019Leary M, Yoshimura N, Chancellor MB (2005) Single institution experience in 110 patients with botulinum toxin-A injection into the bladder or urethra. Urology 65:37\u201341. doi: 10.1016\/j.urology.2004.08.016","journal-title":"Urology"},{"key":"9600_CR26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ncpuro1034","volume":"5","author":"MC Smaldone","year":"2008","unstructured":"Smaldone MC, Chancellor MB (2008) Neuromodulation versus neurotoxin for the treatment of refractory detrusor overactivity: for neurotoxin. Nat Clin Pract 5:120\u2013121. doi: 10.1038\/ncpuro1034","journal-title":"Nat Clin Pract"},{"key":"9600_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1016-3190(08)60019-1","volume":"20","author":"MB Chancellor","year":"2008","unstructured":"Chancellor MB, Costa F, Kuo HC (2008) Neurotoxin versus neuromodulation for the treatment of refractory overactive bladder syndrome. Tzu Chin Med J 20:109\u2013111. doi: 10.1016\/S1016-3190(08)60019-1","journal-title":"Tzu Chin Med J"},{"key":"9600_CR28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","volume":"64","author":"CP Smith","year":"2004","unstructured":"Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB (2004) Botulinum toxin-A has antinociceptive effects in treating interstitial cystitis. Urology 64:871\u2013875. doi: 10.1016\/j.urology.2004.06.073","journal-title":"Urology"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-009-9600-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9600-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:55:30Z","timestamp":1559375730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-009-9600-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9600"],"URL":"https:\/\/doi.org\/10.1007\/s11255-009-9600-7","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2009,7,2]]}}}